Last updated: August 25, 2025
Sponsor: Khyber Teaching Hospital
Overall Status: Active - Recruiting
Phase
4
Condition
Vitiligo
Treatment
Microneedling + NBUVB
Needling + NBUVB
Clinical Study ID
NCT06991972
187/DME/KMC
Ages 15-60 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Both male and female
Age 15-60 years
Patients having vitiligo for more than 1 year
Exclusion
Exclusion Criteria:
Patients with tendency of keloid formation or hypertrophic scarring
Patients with any bleeding disorder, coagulation defect or using anti platelets
Any local infection at the treatment site
Patients who had received systemic therapy in last 6 months
Study Design
Total Participants: 80
Treatment Group(s): 2
Primary Treatment: Microneedling + NBUVB
Phase: 4
Study Start date:
March 01, 2025
Estimated Completion Date:
August 31, 2025
Study Description
Connect with a study center
Khyber Teaching Hospital
Peshawar, Khyber Pakhtunkhwa 25000
PakistanSite Not Available
Khyber Teaching Hospital
Peshawar 1168197, Khyber Pakhtunkhwa 1168873 25000
PakistanActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.